49 results on '"Kaufmann, Manfred"'
Search Results
2. Disseminated tumor cells in the bone marrow of patients with ductal carcinoma in situ
3. Gene expression profiling of luminal B breast cancers reveals NHERF1 as a new marker of endocrine resistance
4. Use of Standard Markers and Incorporation of Molecular Markers Into Breast Cancer Therapy#: Consensus Recommendations From an International Expert Panel
5. Impact of treatment characteristics on response of different breast cancer phenotypes: pooled analysis of the German neo-adjuvant chemotherapy trials
6. Cost-Effectiveness Analysis of Anastrozole versus Tamoxifen in Adjuvant Therapy for Early-Stage Breast Cancer - a Health-Economic Analysis Based on the 100-Month Analysis of the ATAC Trial and the German Health System
7. Data driven derivation of cutoffs from a pool of 3,030 Affymetrix arrays to stratify distinct clinical types of breast cancer
8. Locoregional treatment of primary breast cancer: Consensus recommendations from an International Expert Panel
9. Gene expression of ceramide kinase, galactosyl ceramide synthase and ganglioside GD3 synthase is associated with prognosis in breast cancer
10. Ceramide synthases and ceramide levels are increased in breast cancer tissue
11. Prognostic relevance of glucosylceramide synthase (GCS) expression in breast cancer
12. Microarray analysis of altered sphingolipid metabolism reveals prognostic significance of sphingosine kinase 1 in breast cancer
13. Neoadjuvant Vinorelbine–Capecitabine Versus Docetaxel–Doxorubicin–Cyclophosphamide in Early Nonresponsive Breast Cancer: Phase III Randomized GeparTrio Trial
14. Intensified Neoadjuvant Chemotherapy in Early-Responding Breast Cancer: Phase III Randomized GeparTrio Study
15. Utero-Tubal Sperm Transport and Its Impairment in Endometriosis and Adenomyosis
16. Phyllodes Tumors of the Breast - Diagnostic and Therapeutic Dilemmas
17. The impact of breast cancer awareness and socioeconomic status on willingness to receive breast cancer prevention drugs
18. Extended and continuous use of hormonal contraceptives to reduce menstruation
19. Author reply
20. Recommendations From an International Expert Panel on the Use of Neoadjuvant (Primary) Systemic Treatment of Operable Breast Cancer: An Update
21. Breast carcinoma during pregnancy: International recommendations from an expert meeting
22. Darbepoetin Alfa as Primary Prophylaxis of Anemia in Patients with Breast Cancer Treated Preoperatively with Docetaxel/Doxorubicin/Cyclophosphamide
23. Tumor inhibition by genomically integrated inducible RNAi-cassettes
24. Tamoxifen Versus Control After Adjuvant, Risk-Adapted Chemotherapy in Postmenopausal, Receptor-Negative Patients With Breast Cancer: A Randomized Trial (GABG-IV D-93)—The German Adjuvant Breast Cancer Group
25. Osteoporosis case finding in the general practice: phalangeal radiographic absorptiometry with and without risk factors for osteoporosis to select postmenopausal women eligible for lumbar spine and hip densitometry
26. Use of goserelin in the treatment of breast cancer
27. Long-term risk of breast cancer recurrence: the need for extended adjuvant therapy
28. Conditional inhibition of cancer cell proliferation by tetracycline-responsive, H1 promoter-driven silencing of PLK1
29. Doxorubicin With Cyclophosphamide Followed by Docetaxel Every 21 Days Compared With Doxorubicin and Docetaxel Every 14 Days As Preoperative Treatment in Operable Breast Cancer: The GEPARDUO Study of the German Breast Group
30. Sexual Dysfunction in Breast Cancer Survivors
31. Randomized Phase III Trial of Pegylated Liposomal Doxorubicin Versus Vinorelbine or Mitomycin C Plus Vinblastine in Women With Taxane-Refractory Advanced Breast Cancer
32. Cyclin B1 depletion inhibits proliferation and induces apoptosis in human tumor cells
33. Cancer Inhibition in Nude Mice After Systemic Application of U6 Promoter–Driven Short Hairpin RNAs Against PLK1
34. Uterine contractility and directed sperm transport assessed by hysterosalpingoscintigraphy (HSSG) and intrauterine pressure (IUP) measurement
35. International Expert Panel on the Use of Primary (Preoperative) Systemic Treatment of Operable Breast Cancer: Review and Recommendations
36. EGF-R and Her2/neu overexpressing tumors: independent collectives for treatment of breast cancer by specific monoclonal antibody-therapy
37. Effect of RNA Silencing of Polo-Like Kinase-1 (PLK1) on Apoptosis and Spindle Formation in Human Cancer Cells
38. Dose-Dense Biweekly Doxorubicin/Docetaxel Versus Sequential Neoadjuvant Chemotherapy with Doxorubicin/Cyclophosphamide/Docetaxel in Operable Breast Cancer: Second Interim Analysis
39. Capecitabine in combination with vinorelbin in pretreated patients with metastatic breast cancer - Results of an extended phase II study
40. Hysteroscopic septal resection, the treatment of choice in patients with subseptate uterus: postoperative pregnancy rates
41. Dose-Dense Doxorubicin, Docetaxel, and Granulocyte Colony-Stimulating Factor Support With or Without Tamoxifen as Preoperative Therapy in Patients With Operable Carcinoma of the Breast: A Randomized, Controlled, Open Phase IIb Study
42. Predictive value of serum interleukin-6 and -8 levels in preterm labor or rupture of the membranes
43. Exemestane Is Superior to Megestrol Acetate After Tamoxifen Failure in Postmenopausal Women With Advanced Breast Cancer: Results of a Phase III Randomized Double-Blind Trial
44. First line single agent mitoxantrone in the treatment of high risk metastatic breast cancer patients is as effective as combination chemotherapy but less toxic: No difference in survival but higher quality of life shown in a multicenter randomized trial.
45. Clodronate in Metastatic Breast Cancer
46. Reduction in New Metastases in Breast Cancer with Adjuvant Clodronate Treatment
47. CD44 isoforms in prognosis of breast cancer
48. CD44 variant exon epitopes in primary breast cancer and length of survival
49. Effect of menstrual phase on surgical treatment of breast cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.